Skip to main content
Date Issued
Submitting OIG
Department of Health & Human Services OIG
Other Participating OIGs
Department of Health & Human Services OIG
Agencies Reviewed/Investigated
Department of Health & Human Services
Report Number
A-09-20-03003
Report Description

Facet-joint injections of an anesthetic with or without a steroid are used to diagnose or treat chronic neck and back pain. To address inappropriate billing for pain management tied to overuse of spinal facet-joint injections, the Medicare Administrative Contractors (MACs) developed a limitation of coverage.1 The coverage limitation allows physicians to be reimbursed, during a rolling 12-month period,2 for a maximum of five sessions3 in which facet-joint injections are delivered to the lumbar region of the spine (lumber spine) and a maximum of five sessions in which facet-joint injections are delivered to the cervical and thoracic regions of the spine (cervical/thoracic spine).4 (We refer to injection sessions in these two spinal areas during a rolling 12-month period as “selected facet-joint injection sessions.”) However, Noridian Healthcare Solutions, LLC (Noridian), one of the MACs, confirmed that a common error identified in audits it performed during calendar years 2016 through 2018 was that Medicare paid for more than five sessions in which facet-joint injections were delivered to the lumbar or cervical/thoracic spines during a rolling 12-month period. Therefore, we conducted this audit to determine whether Medicare made improper payments for selected facet-joint sessions in the MAC jurisdictions that had a coverage limitation from January 1, 2017, through May 31, 2019 (audit period).

Report Type
Audit
Agency Wide
Yes
Number of Recommendations
5
Questioned Costs
$0
Funds for Better Use
$0

Open Recommendations

This report has 1 open recommendations.
Recommendation Number Significant Recommendation Recommended Questioned Costs Recommended Funds for Better Use Additional Details
269577 No $0 $0

For the 11 MAC jurisdictions with a coverage limitation for the number of facet-joint injection sessions during a rolling 12-month period, we recommend that the Centers for Medicare & Medicaid Services direct the MACs that oversee the 11 jurisdictions to review claims for facet-joint injections after our audit period to identify instances in which Medicare paid physicians for more than 5 injection sessions received by beneficiaries during a rolling 12-month period and recover any improper payments identified.

Department of Health & Human Services OIG

United States